| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bioptik Technology Incorporation (TWO: 4161)
4161 Technical Analysis
5
| As on 15th Jan 2026 4161 STOCK Price closed @ 27.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 30.90 & Strong Sell for SHORT-TERM with Stoploss of 32.63 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4161STOCK Price
| Open | 25.30 | Change | Price | % |
| High | 27.00 | 1 Day | 1.95 | 7.78 |
| Low | 25.05 | 1 Week | 2.20 | 8.87 |
| Close | 27.00 | 1 Month | 1.40 | 5.47 |
| Volume | 201782 | 1 Year | -5.35 | -16.54 |
| 52 Week High 35.15 | 52 Week Low 24.75 | ||||
TWO Taiwan Most Active Stocks
| 1815 | 93.20 | 5.91% |
| 6182 | 39.90 | 0.76% |
| 6173 | 74.20 | -3.13% |
| 8042 | 71.00 | 0.85% |
| 3236 | 37.90 | 5.57% |
| 5328 | 25.85 | 10.00% |
| 8043 | 100.50 | 1.82% |
| 5347 | 127.00 | 2.42% |
| 6127 | 40.60 | -3.33% |
| 3105 | 222.00 | 3.02% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4161 Daily Charts |
4161 Intraday Charts |
Whats New @ Bazaartrend |
4161 Free Analysis |
|
|
4161 Important Levels Intraday
| RESISTANCE | 30.76 |
| RESISTANCE | 29.55 |
| RESISTANCE | 28.81 |
| RESISTANCE | 28.06 |
| SUPPORT | 25.94 |
| SUPPORT | 25.19 |
| SUPPORT | 24.45 |
| SUPPORT | 23.24 |
4161 Forecast January 2026
| 4th UP Forecast | 39.81 |
| 3rd UP Forecast | 35.7 |
| 2nd UP Forecast | 33.16 |
| 1st UP Forecast | 30.62 |
| 1st DOWN Forecast | 23.38 |
| 2nd DOWN Forecast | 20.84 |
| 3rd DOWN Forecast | 18.3 |
| 4th DOWN Forecast | 14.19 |
4161 Weekly Forecast
| 4th UP Forecast | 33.74 |
| 3rd UP Forecast | 31.58 |
| 2nd UP Forecast | 30.24 |
| 1st UP Forecast | 28.91 |
| 1st DOWN Forecast | 25.09 |
| 2nd DOWN Forecast | 23.76 |
| 3rd DOWN Forecast | 22.42 |
| 4th DOWN Forecast | 20.26 |
4161 Forecast2026
| 4th UP Forecast | 48.39 |
| 3rd UP Forecast | 41.53 |
| 2nd UP Forecast | 37.29 |
| 1st UP Forecast | 33.05 |
| 1st DOWN Forecast | 20.95 |
| 2nd DOWN Forecast | 16.71 |
| 3rd DOWN Forecast | 12.47 |
| 4th DOWN Forecast | 5.61 |
Bioptik Technology Incorporation ( TWO Taiwan Symbol : 4161 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4161 Other Details
| Segment | EQ | |
| Market Capital | 1250218880.00 | |
| Sector | Healthcare | |
| Industry | Medical Devices | |
| Offical website | > echo $website ; ?> | |
4161 Address
![]() |
||
4161 Latest News
4161 Business Profile
Bioptik Technology Incorporation researches, develops, produces, and sells medical devices and reagents in Taiwan and internationally. The company offers EasyMate blood glucose monitoring systems; blood glucose/cholesterol/uric acid monitoring systems and its strips; and hyaluronic acid skin care products. It also provides skin care products and dietary supplements, as well as biodiesel products. The company was founded in 1999 and is headquartered in Zhunan, Taiwan. Address: No. 188, Jhonghua South Road, Zhunan, Taiwan, 35057
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

